Humberto de Carvalho Aragão Neto
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Humberto de Carvalho Aragão Neto has a total of 48 co-authors. Here are the top co-authors by number of shared publications:
- Reinaldo Nóbrega de Almeida
Universidade Federal da Paraíba, Brazil
3 shared publications - Abrahão Alves de Oliveira Filho
Universidade Federal de Campina Grande, Brazil
2 shared publications - Francisco Cunha Nunes Correio
Hospital Universitário Lauro Wanderley
2 shared publications - José Maria Barbosa-Filho
Pharmaceutical Technology Laboratory, Department of Pharmaceutical Sciences, Federal University of Paraíba, João Pessoa 58051-900, Paraíba, Brazil
2 shared publications Adriana M.F.O. Golzio
Laboratory of Psychopharmacology, Federal University of Paraíba (UFPB), João Pessoa, PB, Brazil
1 shared publication- Aleson Pereira de Sousa
Universidade Federal da Paraíba
1 shared publication
Latest Publications
- Open Access
- 1 January 2025
- Published by FapUNIFESP (SciELO) in Brazilian Journal of Biology
- Vol. 85, e286667
Umbelliferone presents orofacial antinociceptive and anti-inflammatory activity via reduction of TNF-α in mice
Pain is a normal response of the central nervous system to trauma, infections, neoplasms, neuropathies, and inflammation. It can arise from physical, emotional, or cognitive conditions, and is classified as orofacial pain when it affects the mouth and face. Umbelliferone, a coumarin from the umbelliferous plant family, is an important component of essential oils, and possesses antioxidant, curative, anti-inflammatory, and anti-tumor activity. The aim of this study was to investigate the orofacial antinociceptive and anti-inflammatory effects of umbelliferone in Swiss male mice Mus musculus, at 3 months of age. Test groups received different doses of umbelliferone (25, 50, or 75 mg/kg, i.p.). The negative control received 0.9% sodium chloride and Tween 80, with the positive control receiving morphine (5 mg/kg, i.p.) or dexamethasone (2 mg/kg, s.c.). We observed a significant reduction in acetic acid-induced abdominal writhing (p<0.001), and a decrease in paw licking in the orofacial nociception test with formalin (p < 0.01). The 50 and 75 mg/kg doses of umbelliferone presented significant reductions in the glutamate (p<0.01) and capsaicin (p<0.01) tests, suggesting activity on glutamatergic receptors and TRPV1. In the carrageenan-induced paw edema test (1%), there was a decrease in limb volume over 240 minutes (p<0.01), suggesting inhibition of the inflammatory process. There was also a reduction in leukocyte count (p<0.001) and TNF-α levels (p<0.001) when compared to the control group, being similar to the animals treated with dexamethasone (p<0.001). It was concluded that umbelliferone exhibits orofacial antinociceptive activity and anti-inflammatory activity via TNF-α. However, further preclinical studies are needed for a better characterization.
- 1 January 2025
- Published by FapUNIFESP (SciELO) in Brazilian Journal of Biology
- Vol. 85, e286667
Open AccessUmbelliferone presents orofacial antinociceptive and anti-inflammatory activity via reduction of TNF-α in mice
Pain is a normal response of the central nervous system to trauma, infections, neoplasms, neuropathies, and inflammation. It can arise from physical, emotional, or cognitive conditions, and is classified as orofacial pain when it affects the mouth and face. Umbelliferone, a coumarin from the umbelliferous plant family, is an important component of essential oils, and possesses antioxidant, curative, anti-inflammatory, and anti-tumor activity. The aim of this study was to investigate the orofacial antinociceptive and anti-inflammatory effects of umbelliferone in Swiss male mice Mus musculus, at 3 months of age. Test groups received different doses of umbelliferone (25, 50, or 75 mg/kg, i.p.). The negative control received 0.9% sodium chloride and Tween 80, with the positive control receiving morphine (5 mg/kg, i.p.) or dexamethasone (2 mg/kg, s.c.). We observed a significant reduction in acetic acid-induced abdominal writhing (p<0.001), and a decrease in paw licking in the orofacial nociception test with formalin (p < 0.01). The 50 and 75 mg/kg doses of umbelliferone presented significant reductions in the glutamate (p<0.01) and capsaicin (p<0.01) tests, suggesting activity on glutamatergic receptors and TRPV1. In the carrageenan-induced paw edema test (1%), there was a decrease in limb volume over 240 minutes (p<0.01), suggesting inhibition of the inflammatory process. There was also a reduction in leukocyte count (p<0.001) and TNF-α levels (p<0.001) when compared to the control group, being similar to the animals treated with dexamethasone (p<0.001). It was concluded that umbelliferone exhibits orofacial antinociceptive activity and anti-inflammatory activity via TNF-α. However, further preclinical studies are needed for a better characterization.
- Open Access
- 23 March 2023
- Published by Research, Society and Development in Research, Society and Development
- Vol. 12 (4)
Correlação entre urocultura e sumário de urina para o diagnóstico de infecção do trato urinário em pacientes Internos num Hospital Universitário do Estado da Paraíba
Urinary tract infection (UTI) is one of the most frequent infections that affect patients in hospitals and can be classified as cystitis or pyelonephritis, depending on the site of infection. The diagnosis of UTI is basically made by performing the urine summary (EAS) and urine culture. Thus, the objective of this study was to conduct a retrospective study from January/2021 to December/2021 based on the database of the clinical analysis laboratory of the University Hospital Lauro Wanderley (HULW) in the state of Paraiba in relation to the alterations presented in the EAS exam, mainly with the markers nitrite and leukocyte esterase from positive urine cultures. The epidemiological data of these infections was also observed, as well as their bacterial incidence. A total of 1817 urine cultures were obtained, of which 837 had a request for EAS concomitantly, and of these 129 urine culture samples were positive, with the prevalent microorganisms being Escherichia coli (36.5%), Klebsiella pneumoniae (20.6 %) and Pseudomonas aeruginosa (8.7%). Nitrite was observed in 16% of the samples and leukocyte esterase in 58%. We conclude that regarding the results of the EAS, leukocyturia proved to be a more sensitive marker to aid in the diagnosis of UTI compared to nitrite, corroborating the specialized scientific literature, with a predominance of UTI in female patients.
- 23 March 2023
- Published by Research, Society and Development in Research, Society and Development
- Vol. 12 (4)
Open AccessCorrelação entre urocultura e sumário de urina para o diagnóstico de infecção do trato urinário em pacientes Internos num Hospital Universitário do Estado da Paraíba
Urinary tract infection (UTI) is one of the most frequent infections that affect patients in hospitals and can be classified as cystitis or pyelonephritis, depending on the site of infection. The diagnosis of UTI is basically made by performing the urine summary (EAS) and urine culture. Thus, the objective of this study was to conduct a retrospective study from January/2021 to December/2021 based on the database of the clinical analysis laboratory of the University Hospital Lauro Wanderley (HULW) in the state of Paraiba in relation to the alterations presented in the EAS exam, mainly with the markers nitrite and leukocyte esterase from positive urine cultures. The epidemiological data of these infections was also observed, as well as their bacterial incidence. A total of 1817 urine cultures were obtained, of which 837 had a request for EAS concomitantly, and of these 129 urine culture samples were positive, with the prevalent microorganisms being Escherichia coli (36.5%), Klebsiella pneumoniae (20.6 %) and Pseudomonas aeruginosa (8.7%). Nitrite was observed in 16% of the samples and leukocyte esterase in 58%. We conclude that regarding the results of the EAS, leukocyturia proved to be a more sensitive marker to aid in the diagnosis of UTI compared to nitrite, corroborating the specialized scientific literature, with a predominance of UTI in female patients.
- Open Access
- 13 May 2022
- Published by Research, Society and Development in Research, Society and Development
- Vol. 11 (7)
Avaliação da citotoxicidade do ácido 3-cumarino carboxílico em eritrócitos humanos
O eritrócito é um tipo celular altamente suscetível peroxidação lipídica e hemólise. Testes in vitro de citotoxicidade são frequentemente usados para rastrear e determinar a toxicidade de vários compostos, principalmente para investigar efeitos diretos sobre a integridade da membrana. As cumarinas (1,2-benzopirona) fazem parte de um grupo de compostos heterocíclicos presentes em várias famílias de plantas. Inúmeras atividades biológicas têm sido demonstradas para cumarinas e seus derivados, incluindo propriedades anti-inflamatórias, antioxidantes, anticancerígenas e antimicrobianas. O objetivo do presente estudo foi investigar pela primeira vez o perfil tóxico de um derivado cumarínico, o ácido 3-cumarino carboxílico, em ensaios citotoxicidade envolvendo eritrócitos humanos. Foram preparadas soluções contendo o ácido 3-cumarino carboxílico nas concentrações de 50, 100, 500 e 1000 µg/mL. Amostras de sangue humano do tipo A, B e O foram coletadas de voluntários saudáveis e submetidas à avaliação de citotoxicidade frente aos ensaios de atividade hemolítica e anti-hemolítica. A substância testada foi capaz de reduzir a lise sobre os eritrócitos humanos dos tipos sanguíneos A, B e O em todas as concentrações testadas. No ensaio de fragilidade osmótica o ácido 3-cumarino carboxílico também foi capaz de proteger os eritrócitos humanos contra a hemólise, nos tipos sanguíneos A, B e O, nas concentrações de 50µg/mL e 100µg/mL. Os resultados de citotoxicidade in vitro indicam que o ácido 3-cumarino carboxílico apresentou baixo percentual de hemólise para eritrócitos humanos dos grupos sanguíneos A, B e O quando em contato direto com essas células, sendo também capaz de proteger a membrana eritrocitária, impedindo a hemólise.
- 13 May 2022
- Published by Research, Society and Development in Research, Society and Development
- Vol. 11 (7)
Open AccessAvaliação da citotoxicidade do ácido 3-cumarino carboxílico em eritrócitos humanos
O eritrócito é um tipo celular altamente suscetível peroxidação lipídica e hemólise. Testes in vitro de citotoxicidade são frequentemente usados para rastrear e determinar a toxicidade de vários compostos, principalmente para investigar efeitos diretos sobre a integridade da membrana. As cumarinas (1,2-benzopirona) fazem parte de um grupo de compostos heterocíclicos presentes em várias famílias de plantas. Inúmeras atividades biológicas têm sido demonstradas para cumarinas e seus derivados, incluindo propriedades anti-inflamatórias, antioxidantes, anticancerígenas e antimicrobianas. O objetivo do presente estudo foi investigar pela primeira vez o perfil tóxico de um derivado cumarínico, o ácido 3-cumarino carboxílico, em ensaios citotoxicidade envolvendo eritrócitos humanos. Foram preparadas soluções contendo o ácido 3-cumarino carboxílico nas concentrações de 50, 100, 500 e 1000 µg/mL. Amostras de sangue humano do tipo A, B e O foram coletadas de voluntários saudáveis e submetidas à avaliação de citotoxicidade frente aos ensaios de atividade hemolítica e anti-hemolítica. A substância testada foi capaz de reduzir a lise sobre os eritrócitos humanos dos tipos sanguíneos A, B e O em todas as concentrações testadas. No ensaio de fragilidade osmótica o ácido 3-cumarino carboxílico também foi capaz de proteger os eritrócitos humanos contra a hemólise, nos tipos sanguíneos A, B e O, nas concentrações de 50µg/mL e 100µg/mL. Os resultados de citotoxicidade in vitro indicam que o ácido 3-cumarino carboxílico apresentou baixo percentual de hemólise para eritrócitos humanos dos grupos sanguíneos A, B e O quando em contato direto com essas células, sendo também capaz de proteger a membrana eritrocitária, impedindo a hemólise.
- Open Access
- 17 April 2022
- Published by Research, Society and Development in Research, Society and Development
- Vol. 11 (6)
Analysis of hematological parameters of COVID-19 / SARS-CoV-2 positive patients treated at a university hospital in northeastern Brazil
The objective of this work was to analyze the hematological parameters of patients positive for COVID-19, admitted to the COVID intensive care unit (ICU-COVID) of the University Hospital Lauro Wanderley (HULW), to correlate these data with the clinical conditions of critically ill patients, compared to patients in the ward of the COVID Infectious Parasitic Diseases Unit (IDP -COVID). The study population consisted of patients in (ICU-COVID) and (IDP-COVID) of both genders, considering children, adolescents, adults, and elderly people hospitalized in this unit with positive serology or molecular tests (RT-PCR). This was a retrospective observational cross-sectional study involving patients in the (ICU-COVID) and (IDP -COVID) of the HULW. The study was carried out in accordance with the requirements of the Research Ethics Committee (CAAE 46718921.4.0000.5183) of the HULW. 152 exams were analyzed. Of these, 88 (58%) were male and the average in relation to the age group was 61.5 years. By correlating the data obtained from inpatients in the COVID-ICU and IDP-COVID, it can be observed in the ICU-COVID patients there was the predominance of leukocytosis (50.4%), as well as lymphopenia (90.9%), neutrophilia (80%) and anemia (70%). Thrombocytopenia is present in 23% of patients in the COVID-ICU and alterations in Prothrombin Time (PT) and Activated Partial Thromboplastin Time (APTT) were identified. These data corroborate the literature, in which the total leukocyte count varies between patients, which may reflect the dominance of lymphopenia or neutrophilia. Taken together, decreased lymphocytes accompanied by mild thrombocytopenia are among the most common abnormal findings that attract attention in the blood count of COVID-19 patients.
- 17 April 2022
- Published by Research, Society and Development in Research, Society and Development
- Vol. 11 (6)
Open AccessAnalysis of hematological parameters of COVID-19 / SARS-CoV-2 positive patients treated at a university hospital in northeastern Brazil
The objective of this work was to analyze the hematological parameters of patients positive for COVID-19, admitted to the COVID intensive care unit (ICU-COVID) of the University Hospital Lauro Wanderley (HULW), to correlate these data with the clinical conditions of critically ill patients, compared to patients in the ward of the COVID Infectious Parasitic Diseases Unit (IDP -COVID). The study population consisted of patients in (ICU-COVID) and (IDP-COVID) of both genders, considering children, adolescents, adults, and elderly people hospitalized in this unit with positive serology or molecular tests (RT-PCR). This was a retrospective observational cross-sectional study involving patients in the (ICU-COVID) and (IDP -COVID) of the HULW. The study was carried out in accordance with the requirements of the Research Ethics Committee (CAAE 46718921.4.0000.5183) of the HULW. 152 exams were analyzed. Of these, 88 (58%) were male and the average in relation to the age group was 61.5 years. By correlating the data obtained from inpatients in the COVID-ICU and IDP-COVID, it can be observed in the ICU-COVID patients there was the predominance of leukocytosis (50.4%), as well as lymphopenia (90.9%), neutrophilia (80%) and anemia (70%). Thrombocytopenia is present in 23% of patients in the COVID-ICU and alterations in Prothrombin Time (PT) and Activated Partial Thromboplastin Time (APTT) were identified. These data corroborate the literature, in which the total leukocyte count varies between patients, which may reflect the dominance of lymphopenia or neutrophilia. Taken together, decreased lymphocytes accompanied by mild thrombocytopenia are among the most common abnormal findings that attract attention in the blood count of COVID-19 patients.
- Open Access
- 14 November 2021
- Published by Research, Society and Development in Research, Society and Development
- Vol. 10 (15)
Epidemiological and laboratory profile of patients confirmed with Covid-19 and admitted to a reference hospital
The new coronavirus, SARS-CoV-2, which causes COVID-19 is easily transmitted from person to person. About 15% develop severe pneumonia and of these, 6% progress to severe acute respiratory syndrome (SARS) and multiple organ failure. Identify biomarkers that can predict which individuals are likely to be affected by severe disease and are at risk of death is crucial. However, the pathophysiology of the disease is not completely elucidated and the characterization of the clinical profile of people infected with SARS-CoV-2 remains unclear. Therefore, the objective of this study was to evaluate the epidemiological and laboratory profile of patients confirmed with COVID-19 and admitted to the University Hospital Lauro Wanderley, based on the correlation of laboratory tests to the evolution of the disease, determination of the most influential variables in the worsening of the disease. Data consisted of complete blood count and serum biochemical analyzes. Overall, 74 patients met all criteria of this study and were included, 40 from the Intensive Care Unit (ICU), and 34 from the Infectious Diseases Infirmary (IDP), both exclusively for patients with COVID-19. Based on these findings, patients with increased WBC count, ALT, AST, and LDH should be closely monitored as these factors predict ICU admission and mortality. Among other laboratory parameters, patients admitted to the ICU have higher levels of D-dimer compared to IDI patients. The results suggests that higher levels of D-dimer on admission is related to a worse prognosis of the disease.
- 14 November 2021
- Published by Research, Society and Development in Research, Society and Development
- Vol. 10 (15)
Open AccessEpidemiological and laboratory profile of patients confirmed with Covid-19 and admitted to a reference hospital
The new coronavirus, SARS-CoV-2, which causes COVID-19 is easily transmitted from person to person. About 15% develop severe pneumonia and of these, 6% progress to severe acute respiratory syndrome (SARS) and multiple organ failure. Identify biomarkers that can predict which individuals are likely to be affected by severe disease and are at risk of death is crucial. However, the pathophysiology of the disease is not completely elucidated and the characterization of the clinical profile of people infected with SARS-CoV-2 remains unclear. Therefore, the objective of this study was to evaluate the epidemiological and laboratory profile of patients confirmed with COVID-19 and admitted to the University Hospital Lauro Wanderley, based on the correlation of laboratory tests to the evolution of the disease, determination of the most influential variables in the worsening of the disease. Data consisted of complete blood count and serum biochemical analyzes. Overall, 74 patients met all criteria of this study and were included, 40 from the Intensive Care Unit (ICU), and 34 from the Infectious Diseases Infirmary (IDP), both exclusively for patients with COVID-19. Based on these findings, patients with increased WBC count, ALT, AST, and LDH should be closely monitored as these factors predict ICU admission and mortality. Among other laboratory parameters, patients admitted to the ICU have higher levels of D-dimer compared to IDI patients. The results suggests that higher levels of D-dimer on admission is related to a worse prognosis of the disease.
- Open Access
- 31 March 2019
- Published by Wiley in Oxidative Medicine and Cellular Longevity
- Vol. 2019, 1-14
2-Allylphenol Reduces IL-1βand TNF-α, Promoting Antinociception through Adenosinergic, Anti-Inflammatory, and Antioxidant Mechanisms
2-Allylphenol (2-AP) is a synthetic phenylpropanoid, structurally related to cardanol, thymol, and ortho-eugenol. Phenylpropanoids are described in the literature as being capable of promoting biological activity. Due to the similarity between 2-AP and other bioactive phenylpropanoids, the present research aims at evaluating the antioxidant, antinociceptive, and anti-inflammatory potential of 2-AP in silico,in vitro, andin vivo. At 30 min prior to the start ofin vivopharmacological testing, administration of 2-AP (25, 50, 75, and 100 mg/kg i.p.), morphine (6 mg/kg i.p.), dexamethasone (2 mg/kg s.c.), or vehicle alone was performed. In the acetic acid-induced abdominal writhing tests, pretreatment with 2-AP significantly reduced the number of abdominal writhes, as well as decreased licking times in the glutamate and formalin tests. Investigation of the mechanism of action using the formalin model led to the conclusion that the opioid system does not participate in its activity. However, the adenosinergic system is involved. In the peritonitis tests, 2-AP inhibited leukocyte migration and reduced releases of proinflammatory mediators TNF-αand IL-1β.In vitroantioxidant assays demonstrated that 2-AP presents significant ability to sequester superoxide radicals.In silicodocking studies confirmed interaction between 2-AP and the adenosine A2a receptor through hydrogen bonds with the critical asparagine 253 residues present in the active site. Investigation of 2-AP demonstrated its nociception inhibition and ability to reduce reactive oxygen species. Its interaction with A2a receptors may well be related to proinflammatory cytokines TNF-αand IL-1βreduction activity, corroborating its antinociceptive effect.
- 31 March 2019
- Published by Wiley in Oxidative Medicine and Cellular Longevity
- Vol. 2019, 1-14
Open Access2-Allylphenol Reduces IL-1βand TNF-α, Promoting Antinociception through Adenosinergic, Anti-Inflammatory, and Antioxidant Mechanisms
2-Allylphenol (2-AP) is a synthetic phenylpropanoid, structurally related to cardanol, thymol, and ortho-eugenol. Phenylpropanoids are described in the literature as being capable of promoting biological activity. Due to the similarity between 2-AP and other bioactive phenylpropanoids, the present research aims at evaluating the antioxidant, antinociceptive, and anti-inflammatory potential of 2-AP in silico,in vitro, andin vivo. At 30 min prior to the start ofin vivopharmacological testing, administration of 2-AP (25, 50, 75, and 100 mg/kg i.p.), morphine (6 mg/kg i.p.), dexamethasone (2 mg/kg s.c.), or vehicle alone was performed. In the acetic acid-induced abdominal writhing tests, pretreatment with 2-AP significantly reduced the number of abdominal writhes, as well as decreased licking times in the glutamate and formalin tests. Investigation of the mechanism of action using the formalin model led to the conclusion that the opioid system does not participate in its activity. However, the adenosinergic system is involved. In the peritonitis tests, 2-AP inhibited leukocyte migration and reduced releases of proinflammatory mediators TNF-αand IL-1β.In vitroantioxidant assays demonstrated that 2-AP presents significant ability to sequester superoxide radicals.In silicodocking studies confirmed interaction between 2-AP and the adenosine A2a receptor through hydrogen bonds with the critical asparagine 253 residues present in the active site. Investigation of 2-AP demonstrated its nociception inhibition and ability to reduce reactive oxygen species. Its interaction with A2a receptors may well be related to proinflammatory cytokines TNF-αand IL-1βreduction activity, corroborating its antinociceptive effect.
- 1 September 2016
- Published by Elsevier in International Immunopharmacology
- Vol. 38, 402-408
Ortho-eugenol exhibits anti-nociceptive and anti-inflammatory activities
- 1 September 2016
- Published by Elsevier in International Immunopharmacology
- Vol. 38, 402-408
Ortho-eugenol exhibits anti-nociceptive and anti-inflammatory activities